Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease

Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease

(2012) Jeanne M. Palmer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clinical Benefit of Response in Chronic Graft-versus-Host Disease

(2012) Yoshihiro Inamoto et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study

(2011) Hildegard T. Greinix et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation

(2011) Y. Inamoto et al.   BLOOD

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies

(2011) G. L. Chen et al.   BLOOD

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

(2011) G. Socie et al.   BLOOD

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

(2011) S. Arai et al.   BLOOD

Treatment of chronic graft-versus-host disease in 2011

(2011) Yoshihiro Inamoto et al.   CURRENT OPINION IN HEMATOLOGY

Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation

(2011) Nandita Khera et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of Short-Term Response and Long-Term Outcomes after Initial Systemic Treatment of Chronic Graft-Versus-Host Disease

(2010) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

(2010) S. J. Kim et al.   HAEMATOLOGICA

Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease

(2009) Jason W. Chien et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

(2009) P. J. Martin et al.   BLOOD

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

(2009) A. C. Vigorito et al.   BLOOD

Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease

(2008) Mary E.D. Flowers et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

(2008) M. E. D. Flowers et al.   BLOOD

Individual Physician Practice Variation in Hematopoietic Cell Transplantation

(2008) Stephanie J. Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Feasibility of NIH consensus criteria for chronic graft-versus-host disease

(2008) B-S Cho et al.   LEUKEMIA